カテゴリー： 世界, 医療/バイオ, LP Information

世界の子癇前症診断市場予測 2023年-2029年

【英語タイトル】Global Preeclampsia Diagnostics Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC05700）・商品コード：LP23DC05700
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の子癇前症診断市場」は、過去の販売実績から2022年の世界の子癇前症診断の総販売量を検討し、2023年から2029年の予測される子癇前症診断の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の子癇前症診断の市場規模を掲載し、XXX百万米ドル規模の世界の子癇前症診断市場の詳細な分析を提供します。本インサイトレポートは、世界の子癇前症診断業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の子癇前症診断市場における各社の独自のポジションをより深く理解するために、子癇前症診断製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の子癇前症診断市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。子癇前症診断の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。子癇前症診断の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。子癇前症診断のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

子癇前症診断の世界主要メーカーとしては、Abbott Laboratories、 ACON Laboratories, Inc.、 ARKRAY, Inc.、 Bio-Rad Laboratories, Inc.、 Cardinal Health、 Danaher Corporation、 Diabetomics, Inc.、 DIRUI Industrial Co., Ltd.、 F. Hoffmann-La Roche Ltd.、 Metabolomic Diagnostics Ltd.、 Sera Prognostics、 Siemens Healthineers AG、 Other prominent playersなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の子癇前症診断市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では子癇前症診断市場をセグメンテーションし、種類別 (試薬、器具)、用途別 (病院、医療センター、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：試薬、器具

・用途別区分：病院、医療センター、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の子癇前症診断市場の10年間の市場状況・展望は？
・世界および地域別に見た子癇前症診断市場成長の要因は何か？
・子癇前症診断の市場機会はエンドマーケットの規模によってどのように変化するのか？
・子癇前症診断のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：子癇前症診断の年間販売量2018-2029、地域別現状・将来分析
・子癇前症診断の種類別セグメント：試薬、器具
・子癇前症診断の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・子癇前症診断の用途別セグメント：病院、医療センター、その他
・子癇前症診断の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の子癇前症診断市場
・企業別のグローバル子癇前症診断市場データ：2018-2023年の年間販売量、市場シェア
・企業別の子癇前症診断の年間売上：2018-2023年の売上、市場シェア
・企業別の子癇前症診断販売価格
・主要企業の子癇前症診断生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

子癇前症診断の地域別レビュー
・地域別の子癇前症診断市場規模2018-2023：年間販売量、売上
・主要国別の子癇前症診断市場規模2018-2023：年間販売量、売上
・南北アメリカの子癇前症診断販売の成長
・アジア太平洋の子癇前症診断販売の成長
・ヨーロッパの子癇前症診断販売の成長
・中東・アフリカの子癇前症診断販売の成長

南北アメリカ市場
・南北アメリカの国別の子癇前症診断販売量、売上（2018-2023）
・南北アメリカの子癇前症診断の種類別販売量
・南北アメリカの子癇前症診断の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の子癇前症診断販売量、売上（2018-2023）
・アジア太平洋の子癇前症診断の種類別販売量
・アジア太平洋の子癇前症診断の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の子癇前症診断販売量、売上（2018-2023）
・ヨーロッパの子癇前症診断の種類別販売量
・ヨーロッパの子癇前症診断の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の子癇前症診断販売量、売上（2018-2023）
・中東・アフリカの子癇前症診断の種類別販売量
・中東・アフリカの子癇前症診断の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・子癇前症診断の製造コスト構造分析
・子癇前症診断の製造プロセス分析
・子癇前症診断の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・子癇前症診断の主要なグローバル販売業者
・子癇前症診断の主要なグローバル顧客

地域別の子癇前症診断市場予測レビュー
・地域別の子癇前症診断市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・子癇前症診断の種類別市場規模予測
・子癇前症診断の用途別市場規模予測

主要企業分析
Abbott Laboratories、 ACON Laboratories, Inc.、 ARKRAY, Inc.、 Bio-Rad Laboratories, Inc.、 Cardinal Health、 Danaher Corporation、 Diabetomics, Inc.、 DIRUI Industrial Co., Ltd.、 F. Hoffmann-La Roche Ltd.、 Metabolomic Diagnostics Ltd.、 Sera Prognostics、 Siemens Healthineers AG、 Other prominent players
・企業情報
・子癇前症診断製品
・子癇前症診断販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Preeclampsia Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Preeclampsia Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Preeclampsia Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Preeclampsia Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Preeclampsia Diagnostics players cover Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., Bio-Rad Laboratories, Inc., Cardinal Health, Danaher Corporation, Diabetomics, Inc., DIRUI Industrial Co., Ltd. and F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Preeclampsia is a specific complication of pregnancy. A systolic blood pressure of at least 140 mmHg or a diastolic blood pressure of at least 90 mmHg during pregnancy, and protein in the urine (proteinuria), both present after 20 weeks of pregnancy, is diagnostic. If only new-onset hypertension, It is called gestational hypertension (without proteinuria or other signs of organ infection). Before the 20th week of pregnancy, some women develop high blood pressure, which is called chronic hypertension. Preeclampsia and chronic hypertension are common hypertensive problems during pregnancy. Preeclampsia usually presents in the third trimester with few symptoms.
LPI (LP Information)’ newest research report, the “Preeclampsia Diagnostics Industry Forecast” looks at past sales and reviews total world Preeclampsia Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Preeclampsia Diagnostics sales for 2023 through 2029. With Preeclampsia Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preeclampsia Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Preeclampsia Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preeclampsia Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preeclampsia Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preeclampsia Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preeclampsia Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Preeclampsia Diagnostics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Reagent
Instrument
Segmentation by application
Hospital
Medical Center
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Abbott Laboratories
ACON Laboratories, Inc.
ARKRAY, Inc.
Bio-Rad Laboratories, Inc.
Cardinal Health
Danaher Corporation
Diabetomics, Inc.
DIRUI Industrial Co., Ltd.
F. Hoffmann-La Roche Ltd.
Metabolomic Diagnostics Ltd.
Sera Prognostics
Siemens Healthineers AG
Other prominent players
Key Questions Addressed in this Report
What is the 10-year outlook for the global Preeclampsia Diagnostics market?
What factors are driving Preeclampsia Diagnostics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Preeclampsia Diagnostics market opportunities vary by end market size?
How does Preeclampsia Diagnostics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Preeclampsia Diagnostics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Preeclampsia Diagnostics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Preeclampsia Diagnostics by Country/Region, 2018, 2022 & 2029
2.2 Preeclampsia Diagnostics Segment by Type
2.2.1 Reagent
2.2.2 Instrument
2.3 Preeclampsia Diagnostics Sales by Type
2.3.1 Global Preeclampsia Diagnostics Sales Market Share by Type (2018-2023)
2.3.2 Global Preeclampsia Diagnostics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Preeclampsia Diagnostics Sale Price by Type (2018-2023)
2.4 Preeclampsia Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Medical Center
2.4.3 Other
2.5 Preeclampsia Diagnostics Sales by Application
2.5.1 Global Preeclampsia Diagnostics Sale Market Share by Application (2018-2023)
2.5.2 Global Preeclampsia Diagnostics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Preeclampsia Diagnostics Sale Price by Application (2018-2023)
3 Global Preeclampsia Diagnostics by Company
3.1 Global Preeclampsia Diagnostics Breakdown Data by Company
3.1.1 Global Preeclampsia Diagnostics Annual Sales by Company (2018-2023)
3.1.2 Global Preeclampsia Diagnostics Sales Market Share by Company (2018-2023)
3.2 Global Preeclampsia Diagnostics Annual Revenue by Company (2018-2023)
3.2.1 Global Preeclampsia Diagnostics Revenue by Company (2018-2023)
3.2.2 Global Preeclampsia Diagnostics Revenue Market Share by Company (2018-2023)
3.3 Global Preeclampsia Diagnostics Sale Price by Company
3.4 Key Manufacturers Preeclampsia Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preeclampsia Diagnostics Product Location Distribution
3.4.2 Players Preeclampsia Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Preeclampsia Diagnostics by Geographic Region
4.1 World Historic Preeclampsia Diagnostics Market Size by Geographic Region (2018-2023)
4.1.1 Global Preeclampsia Diagnostics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Preeclampsia Diagnostics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Preeclampsia Diagnostics Market Size by Country/Region (2018-2023)
4.2.1 Global Preeclampsia Diagnostics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Preeclampsia Diagnostics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Preeclampsia Diagnostics Sales Growth
4.4 APAC Preeclampsia Diagnostics Sales Growth
4.5 Europe Preeclampsia Diagnostics Sales Growth
4.6 Middle East & Africa Preeclampsia Diagnostics Sales Growth
5 Americas
5.1 Americas Preeclampsia Diagnostics Sales by Country
5.1.1 Americas Preeclampsia Diagnostics Sales by Country (2018-2023)
5.1.2 Americas Preeclampsia Diagnostics Revenue by Country (2018-2023)
5.2 Americas Preeclampsia Diagnostics Sales by Type
5.3 Americas Preeclampsia Diagnostics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preeclampsia Diagnostics Sales by Region
6.1.1 APAC Preeclampsia Diagnostics Sales by Region (2018-2023)
6.1.2 APAC Preeclampsia Diagnostics Revenue by Region (2018-2023)
6.2 APAC Preeclampsia Diagnostics Sales by Type
6.3 APAC Preeclampsia Diagnostics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Preeclampsia Diagnostics by Country
7.1.1 Europe Preeclampsia Diagnostics Sales by Country (2018-2023)
7.1.2 Europe Preeclampsia Diagnostics Revenue by Country (2018-2023)
7.2 Europe Preeclampsia Diagnostics Sales by Type
7.3 Europe Preeclampsia Diagnostics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Preeclampsia Diagnostics by Country
8.1.1 Middle East & Africa Preeclampsia Diagnostics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Preeclampsia Diagnostics Revenue by Country (2018-2023)
8.2 Middle East & Africa Preeclampsia Diagnostics Sales by Type
8.3 Middle East & Africa Preeclampsia Diagnostics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preeclampsia Diagnostics
10.3 Manufacturing Process Analysis of Preeclampsia Diagnostics
10.4 Industry Chain Structure of Preeclampsia Diagnostics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preeclampsia Diagnostics Distributors
11.3 Preeclampsia Diagnostics Customer
12 World Forecast Review for Preeclampsia Diagnostics by Geographic Region
12.1 Global Preeclampsia Diagnostics Market Size Forecast by Region
12.1.1 Global Preeclampsia Diagnostics Forecast by Region (2024-2029)
12.1.2 Global Preeclampsia Diagnostics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Preeclampsia Diagnostics Forecast by Type
12.7 Global Preeclampsia Diagnostics Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Preeclampsia Diagnostics Product Portfolios and Specifications
13.1.3 Abbott Laboratories Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 ACON Laboratories, Inc.
13.2.1 ACON Laboratories, Inc. Company Information
13.2.2 ACON Laboratories, Inc. Preeclampsia Diagnostics Product Portfolios and Specifications
13.2.3 ACON Laboratories, Inc. Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 ACON Laboratories, Inc. Main Business Overview
13.2.5 ACON Laboratories, Inc. Latest Developments
13.3 ARKRAY, Inc.
13.3.1 ARKRAY, Inc. Company Information
13.3.2 ARKRAY, Inc. Preeclampsia Diagnostics Product Portfolios and Specifications
13.3.3 ARKRAY, Inc. Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ARKRAY, Inc. Main Business Overview
13.3.5 ARKRAY, Inc. Latest Developments
13.4 Bio-Rad Laboratories, Inc.
13.4.1 Bio-Rad Laboratories, Inc. Company Information
13.4.2 Bio-Rad Laboratories, Inc. Preeclampsia Diagnostics Product Portfolios and Specifications
13.4.3 Bio-Rad Laboratories, Inc. Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bio-Rad Laboratories, Inc. Main Business Overview
13.4.5 Bio-Rad Laboratories, Inc. Latest Developments
13.5 Cardinal Health
13.5.1 Cardinal Health Company Information
13.5.2 Cardinal Health Preeclampsia Diagnostics Product Portfolios and Specifications
13.5.3 Cardinal Health Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cardinal Health Main Business Overview
13.5.5 Cardinal Health Latest Developments
13.6 Danaher Corporation
13.6.1 Danaher Corporation Company Information
13.6.2 Danaher Corporation Preeclampsia Diagnostics Product Portfolios and Specifications
13.6.3 Danaher Corporation Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Danaher Corporation Main Business Overview
13.6.5 Danaher Corporation Latest Developments
13.7 Diabetomics, Inc.
13.7.1 Diabetomics, Inc. Company Information
13.7.2 Diabetomics, Inc. Preeclampsia Diagnostics Product Portfolios and Specifications
13.7.3 Diabetomics, Inc. Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Diabetomics, Inc. Main Business Overview
13.7.5 Diabetomics, Inc. Latest Developments
13.8 DIRUI Industrial Co., Ltd.
13.8.1 DIRUI Industrial Co., Ltd. Company Information
13.8.2 DIRUI Industrial Co., Ltd. Preeclampsia Diagnostics Product Portfolios and Specifications
13.8.3 DIRUI Industrial Co., Ltd. Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 DIRUI Industrial Co., Ltd. Main Business Overview
13.8.5 DIRUI Industrial Co., Ltd. Latest Developments
13.9 F. Hoffmann-La Roche Ltd.
13.9.1 F. Hoffmann-La Roche Ltd. Company Information
13.9.2 F. Hoffmann-La Roche Ltd. Preeclampsia Diagnostics Product Portfolios and Specifications
13.9.3 F. Hoffmann-La Roche Ltd. Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.9.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.10 Metabolomic Diagnostics Ltd.
13.10.1 Metabolomic Diagnostics Ltd. Company Information
13.10.2 Metabolomic Diagnostics Ltd. Preeclampsia Diagnostics Product Portfolios and Specifications
13.10.3 Metabolomic Diagnostics Ltd. Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Metabolomic Diagnostics Ltd. Main Business Overview
13.10.5 Metabolomic Diagnostics Ltd. Latest Developments
13.11 Sera Prognostics
13.11.1 Sera Prognostics Company Information
13.11.2 Sera Prognostics Preeclampsia Diagnostics Product Portfolios and Specifications
13.11.3 Sera Prognostics Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sera Prognostics Main Business Overview
13.11.5 Sera Prognostics Latest Developments
13.12 Siemens Healthineers AG
13.12.1 Siemens Healthineers AG Company Information
13.12.2 Siemens Healthineers AG Preeclampsia Diagnostics Product Portfolios and Specifications
13.12.3 Siemens Healthineers AG Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Siemens Healthineers AG Main Business Overview
13.12.5 Siemens Healthineers AG Latest Developments
13.13 Other prominent players
13.13.1 Other prominent players Company Information
13.13.2 Other prominent players Preeclampsia Diagnostics Product Portfolios and Specifications
13.13.3 Other prominent players Preeclampsia Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Other prominent players Main Business Overview
13.13.5 Other prominent players Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Preeclampsia Diagnostics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Preeclampsia Diagnostics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Reagent
Table 4. Major Players of Instrument
Table 5. Global Preeclampsia Diagnostics Sales by Type (2018-2023) & (K Units)
Table 6. Global Preeclampsia Diagnostics Sales Market Share by Type (2018-2023)
Table 7. Global Preeclampsia Diagnostics Revenue by Type (2018-2023) & ($ million)
Table 8. Global Preeclampsia Diagnostics Revenue Market Share by Type (2018-2023)
Table 9. Global Preeclampsia Diagnostics Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Preeclampsia Diagnostics Sales by Application (2018-2023) & (K Units)
Table 11. Global Preeclampsia Diagnostics Sales Market Share by Application (2018-2023)
Table 12. Global Preeclampsia Diagnostics Revenue by Application (2018-2023)
Table 13. Global Preeclampsia Diagnostics Revenue Market Share by Application (2018-2023)
Table 14. Global Preeclampsia Diagnostics Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Preeclampsia Diagnostics Sales by Company (2018-2023) & (K Units)
Table 16. Global Preeclampsia Diagnostics Sales Market Share by Company (2018-2023)
Table 17. Global Preeclampsia Diagnostics Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Preeclampsia Diagnostics Revenue Market Share by Company (2018-2023)
Table 19. Global Preeclampsia Diagnostics Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Preeclampsia Diagnostics Producing Area Distribution and Sales Area
Table 21. Players Preeclampsia Diagnostics Products Offered
Table 22. Preeclampsia Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Preeclampsia Diagnostics Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Preeclampsia Diagnostics Sales Market Share Geographic Region (2018-2023)
Table 27. Global Preeclampsia Diagnostics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Preeclampsia Diagnostics Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Preeclampsia Diagnostics Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Preeclampsia Diagnostics Sales Market Share by Country/Region (2018-2023)
Table 31. Global Preeclampsia Diagnostics Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Preeclampsia Diagnostics Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Preeclampsia Diagnostics Sales by Country (2018-2023) & (K Units)
Table 34. Americas Preeclampsia Diagnostics Sales Market Share by Country (2018-2023)
Table 35. Americas Preeclampsia Diagnostics Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Preeclampsia Diagnostics Revenue Market Share by Country (2018-2023)
Table 37. Americas Preeclampsia Diagnostics Sales by Type (2018-2023) & (K Units)
Table 38. Americas Preeclampsia Diagnostics Sales by Application (2018-2023) & (K Units)
Table 39. APAC Preeclampsia Diagnostics Sales by Region (2018-2023) & (K Units)
Table 40. APAC Preeclampsia Diagnostics Sales Market Share by Region (2018-2023)
Table 41. APAC Preeclampsia Diagnostics Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Preeclampsia Diagnostics Revenue Market Share by Region (2018-2023)
Table 43. APAC Preeclampsia Diagnostics Sales by Type (2018-2023) & (K Units)
Table 44. APAC Preeclampsia Diagnostics Sales by Application (2018-2023) & (K Units)
Table 45. Europe Preeclampsia Diagnostics Sales by Country (2018-2023) & (K Units)
Table 46. Europe Preeclampsia Diagnostics Sales Market Share by Country (2018-2023)
Table 47. Europe Preeclampsia Diagnostics Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Preeclampsia Diagnostics Revenue Market Share by Country (2018-2023)
Table 49. Europe Preeclampsia Diagnostics Sales by Type (2018-2023) & (K Units)
Table 50. Europe Preeclampsia Diagnostics Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Preeclampsia Diagnostics Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Preeclampsia Diagnostics Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Preeclampsia Diagnostics Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Preeclampsia Diagnostics Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Preeclampsia Diagnostics Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Preeclampsia Diagnostics Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Preeclampsia Diagnostics
Table 58. Key Market Challenges & Risks of Preeclampsia Diagnostics
Table 59. Key Industry Trends of Preeclampsia Diagnostics
Table 60. Preeclampsia Diagnostics Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Preeclampsia Diagnostics Distributors List
Table 63. Preeclampsia Diagnostics Customer List
Table 64. Global Preeclampsia Diagnostics Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Preeclampsia Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Preeclampsia Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Preeclampsia Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Preeclampsia Diagnostics Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Preeclampsia Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Preeclampsia Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Preeclampsia Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Preeclampsia Diagnostics Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Preeclampsia Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Preeclampsia Diagnostics Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Preeclampsia Diagnostics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Preeclampsia Diagnostics Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Preeclampsia Diagnostics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abbott Laboratories Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Laboratories Preeclampsia Diagnostics Product Portfolios and Specifications
Table 80. Abbott Laboratories Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abbott Laboratories Main Business
Table 82. Abbott Laboratories Latest Developments
Table 83. ACON Laboratories, Inc. Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 84. ACON Laboratories, Inc. Preeclampsia Diagnostics Product Portfolios and Specifications
Table 85. ACON Laboratories, Inc. Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. ACON Laboratories, Inc. Main Business
Table 87. ACON Laboratories, Inc. Latest Developments
Table 88. ARKRAY, Inc. Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 89. ARKRAY, Inc. Preeclampsia Diagnostics Product Portfolios and Specifications
Table 90. ARKRAY, Inc. Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. ARKRAY, Inc. Main Business
Table 92. ARKRAY, Inc. Latest Developments
Table 93. Bio-Rad Laboratories, Inc. Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 94. Bio-Rad Laboratories, Inc. Preeclampsia Diagnostics Product Portfolios and Specifications
Table 95. Bio-Rad Laboratories, Inc. Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Bio-Rad Laboratories, Inc. Main Business
Table 97. Bio-Rad Laboratories, Inc. Latest Developments
Table 98. Cardinal Health Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 99. Cardinal Health Preeclampsia Diagnostics Product Portfolios and Specifications
Table 100. Cardinal Health Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Cardinal Health Main Business
Table 102. Cardinal Health Latest Developments
Table 103. Danaher Corporation Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 104. Danaher Corporation Preeclampsia Diagnostics Product Portfolios and Specifications
Table 105. Danaher Corporation Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Danaher Corporation Main Business
Table 107. Danaher Corporation Latest Developments
Table 108. Diabetomics, Inc. Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 109. Diabetomics, Inc. Preeclampsia Diagnostics Product Portfolios and Specifications
Table 110. Diabetomics, Inc. Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Diabetomics, Inc. Main Business
Table 112. Diabetomics, Inc. Latest Developments
Table 113. DIRUI Industrial Co., Ltd. Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 114. DIRUI Industrial Co., Ltd. Preeclampsia Diagnostics Product Portfolios and Specifications
Table 115. DIRUI Industrial Co., Ltd. Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. DIRUI Industrial Co., Ltd. Main Business
Table 117. DIRUI Industrial Co., Ltd. Latest Developments
Table 118. F. Hoffmann-La Roche Ltd. Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 119. F. Hoffmann-La Roche Ltd. Preeclampsia Diagnostics Product Portfolios and Specifications
Table 120. F. Hoffmann-La Roche Ltd. Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. F. Hoffmann-La Roche Ltd. Main Business
Table 122. F. Hoffmann-La Roche Ltd. Latest Developments
Table 123. Metabolomic Diagnostics Ltd. Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 124. Metabolomic Diagnostics Ltd. Preeclampsia Diagnostics Product Portfolios and Specifications
Table 125. Metabolomic Diagnostics Ltd. Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Metabolomic Diagnostics Ltd. Main Business
Table 127. Metabolomic Diagnostics Ltd. Latest Developments
Table 128. Sera Prognostics Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 129. Sera Prognostics Preeclampsia Diagnostics Product Portfolios and Specifications
Table 130. Sera Prognostics Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Sera Prognostics Main Business
Table 132. Sera Prognostics Latest Developments
Table 133. Siemens Healthineers AG Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 134. Siemens Healthineers AG Preeclampsia Diagnostics Product Portfolios and Specifications
Table 135. Siemens Healthineers AG Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Siemens Healthineers AG Main Business
Table 137. Siemens Healthineers AG Latest Developments
Table 138. Other prominent players Basic Information, Preeclampsia Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 139. Other prominent players Preeclampsia Diagnostics Product Portfolios and Specifications
Table 140. Other prominent players Preeclampsia Diagnostics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Other prominent players Main Business
Table 142. Other prominent players Latest Developments
List of Figures
Figure 1. Picture of Preeclampsia Diagnostics
Figure 2. Preeclampsia Diagnostics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preeclampsia Diagnostics Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Preeclampsia Diagnostics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Preeclampsia Diagnostics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Reagent
Figure 10. Product Picture of Instrument
Figure 11. Global Preeclampsia Diagnostics Sales Market Share by Type in 2022
Figure 12. Global Preeclampsia Diagnostics Revenue Market Share by Type (2018-2023)
Figure 13. Preeclampsia Diagnostics Consumed in Hospital
Figure 14. Global Preeclampsia Diagnostics Market: Hospital (2018-2023) & (K Units)
Figure 15. Preeclampsia Diagnostics Consumed in Medical Center
Figure 16. Global Preeclampsia Diagnostics Market: Medical Center (2018-2023) & (K Units)
Figure 17. Preeclampsia Diagnostics Consumed in Other
Figure 18. Global Preeclampsia Diagnostics Market: Other (2018-2023) & (K Units)
Figure 19. Global Preeclampsia Diagnostics Sales Market Share by Application (2022)
Figure 20. Global Preeclampsia Diagnostics Revenue Market Share by Application in 2022
Figure 21. Preeclampsia Diagnostics Sales Market by Company in 2022 (K Units)
Figure 22. Global Preeclampsia Diagnostics Sales Market Share by Company in 2022
Figure 23. Preeclampsia Diagnostics Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Preeclampsia Diagnostics Revenue Market Share by Company in 2022
Figure 25. Global Preeclampsia Diagnostics Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Preeclampsia Diagnostics Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Preeclampsia Diagnostics Sales 2018-2023 (K Units)
Figure 28. Americas Preeclampsia Diagnostics Revenue 2018-2023 ($ Millions)
Figure 29. APAC Preeclampsia Diagnostics Sales 2018-2023 (K Units)
Figure 30. APAC Preeclampsia Diagnostics Revenue 2018-2023 ($ Millions)
Figure 31. Europe Preeclampsia Diagnostics Sales 2018-2023 (K Units)
Figure 32. Europe Preeclampsia Diagnostics Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Preeclampsia Diagnostics Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Preeclampsia Diagnostics Revenue 2018-2023 ($ Millions)
Figure 35. Americas Preeclampsia Diagnostics Sales Market Share by Country in 2022
Figure 36. Americas Preeclampsia Diagnostics Revenue Market Share by Country in 2022
Figure 37. Americas Preeclampsia Diagnostics Sales Market Share by Type (2018-2023)
Figure 38. Americas Preeclampsia Diagnostics Sales Market Share by Application (2018-2023)
Figure 39. United States Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Preeclampsia Diagnostics Sales Market Share by Region in 2022
Figure 44. APAC Preeclampsia Diagnostics Revenue Market Share by Regions in 2022
Figure 45. APAC Preeclampsia Diagnostics Sales Market Share by Type (2018-2023)
Figure 46. APAC Preeclampsia Diagnostics Sales Market Share by Application (2018-2023)
Figure 47. China Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Preeclampsia Diagnostics Sales Market Share by Country in 2022
Figure 55. Europe Preeclampsia Diagnostics Revenue Market Share by Country in 2022
Figure 56. Europe Preeclampsia Diagnostics Sales Market Share by Type (2018-2023)
Figure 57. Europe Preeclampsia Diagnostics Sales Market Share by Application (2018-2023)
Figure 58. Germany Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Preeclampsia Diagnostics Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Preeclampsia Diagnostics Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Preeclampsia Diagnostics Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Preeclampsia Diagnostics Sales Market Share by Application (2018-2023)
Figure 67. Egypt Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Preeclampsia Diagnostics Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Preeclampsia Diagnostics in 2022
Figure 73. Manufacturing Process Analysis of Preeclampsia Diagnostics
Figure 74. Industry Chain Structure of Preeclampsia Diagnostics
Figure 75. Channels of Distribution
Figure 76. Global Preeclampsia Diagnostics Sales Market Forecast by Region (2024-2029)
Figure 77. Global Preeclampsia Diagnostics Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Preeclampsia Diagnostics Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Preeclampsia Diagnostics Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Preeclampsia Diagnostics Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Preeclampsia Diagnostics Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の子癇前症診断市場予測 2023年-2029年] (コード：LP23DC05700)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の子癇前症診断市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の鼻咽頭採取キット市場予測 2023年-2029年
  • 世界の尿路感染症テストストリップ市場予測 2023年-2029年
  • 世界の獣医用抗菌剤感受性試験装置&コンポーネント市場予測 2023年-2029年
  • 世界の超高速全自動化学発光免疫測定装置市場予測 2023年-2029年
  • 世界の自動血液凝固分析パイプライン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆